Symbol="PHAR"
AssetType="Common Stock"
Name="Pharming Group NV"
Description="Pharming Group NV, a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Leiden, the Netherlands."
CIK="1828316"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="DARWINWEG 24, LEIDEN, NL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="782388000"
EBITDA="-933000"
PERatio="None"
PEGRatio="None"
BookValue="3.1"
DividendPerShare="0"
DividendYield="0"
EPS="-0.05"
RevenuePerShareTTM="3.17"
ProfitMargin="-0.0099"
OperatingMarginTTM="-0.0304"
ReturnOnAssetsTTM="-0.0094"
ReturnOnEquityTTM="-0.0101"
RevenueTTM="201546000"
GrossProfitTTM="188060000"
DilutedEPSTTM="-0.05"
QuarterlyEarningsGrowthYOY="2.089"
QuarterlyRevenueGrowthYOY="-0.087"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="156.25"
PriceToSalesRatioTTM="3.634"
PriceToBookRatio="4.063"
EVToRevenue="3.539"
EVToEBITDA="12.15"
Beta="0.869"
num_52WeekHigh="17.81"
num_52WeekLow="7.6"
num_50DayMovingAverage="11.88"
num_200DayMovingAverage="11.79"
SharesOutstanding="65635000"
DividendDate="None"
ExDividendDate="None"
symbol="PHAR"
open="11.86"
high="11.86"
low="11.86"
price="11.86"
volume="202.00"
latest_trading_day="2023-07-25"
previous_close="12.50"
change="-0.64"
change_percent="-5.1264%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="29"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="71"
Volume_recent_avg="16834"
Change_recent_avg="0.03"
Delta_recent_avg="0.54"
Variance_recent_avg="0.27"
Change_ratio_recent_avg="0.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="71"
Aroon_momentum_negative="29"
image_negative_thumbnail_id_1="170"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0006.jpeg"
image_negative_thumbnail_id_2="1102"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0135.jpeg"
image_neutral_thumbnail_id_1="524"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_neutral_thumbnail_id_2="581"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_positive_thumbnail_id_1="963"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0125.jpeg"
image_positive_thumbnail_id_2="614"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0094.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
